Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SK-10 by Guangzhou Zhiyi Biotechnology for Chemotherapy-Induced Diarrhea (CID): Likelihood of Approval
SK-10 is under clinical development by Guangzhou Zhiyi Biotechnology and currently in Phase I for Chemotherapy-Induced Diarrhea (CID). According to...